Trial Profile
Food-Effect Bioavailability Study of AQ-13, a Candidate Antimalarial
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 16 Mar 2020
Price :
$35
*
At a glance
- Drugs AQ 13 (Primary)
- Indications Falciparum malaria
- Focus Adverse reactions; Pharmacokinetics
- 10 Mar 2020 Status changed from recruiting to completed.